EOLS · Evolus
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Market Cap
510.6M
52 Wk Range
$3.86 - $9.31
Previous Close
$7.80
Open
$7.77
Volume
430,125
Day Range
$7.61 - $7.83
Enterprise Value
648M
Cash
45.17M
Avg Qtr Burn
-3.587M
Insider Ownership
11.25%
Institutional Own.
77.74%
Qtr Updated
Jun 30th 2026
